Emmessar Biotech & Nutrition informs about disclosure

04 Sep 2023 Evaluate
In terms of Regulation 34 of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulation, 2011, Emmessar Biotech & Nutrition has informed that Mathurakavi Srinivasa Raghavan Ayyangar, Chief Promoter, have acquired 5026 equity shares of the company between August 30 & August 31, 2023, through open market. It has enclosed the disclosure under Regulation, 29(2) of the SEBI (SAST) Regulation 2011.

The above information is a part of company’s filings submitted to BSE.

Emmessar Biotech&Nut Share Price

34.79 0.74 (2.17%)
17-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1751.05
Dr. Reddys Lab 1163.70
Cipla 1515.45
Lupin 1936.75
Zydus Lifesciences 831.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...